IL1B and neoplasm: We therefore evaluated whether the anti-tumor activity of LFs was associated with its anti-inflammatory properties through inhibiting pro-inflammatory cytokines and mediators (IL-1β, IL-6, TNF-α, iNOS and Cox-2).